A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes.
Villarraza J, Fuselli A, Gugliotta A, Garay E, Rodríguez MC, Fontana D, Antuña S, Gastaldi V, Battagliotti JM, Tardivo MB, Alvarez D, Castro E, Cassataro J, Ceaglio N, Prieto C.
Villarraza J, et al. Among authors: antuna s.
Appl Microbiol Biotechnol. 2023 Jun;107(11):3429-3441. doi: 10.1007/s00253-023-12520-5. Epub 2023 Apr 24.
Appl Microbiol Biotechnol. 2023.
PMID: 37093307
Free PMC article.